ALS-specific peptide composition
US7763710B2 · kind B2 · utility
6Cited by
4References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 24, 2008 |
| Grant date | Jul 27, 2010 |
| Priority date | — |
| Expiry date | Sep 24, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2828
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to a composition for eliciting an immune response in an animal to produce an antibody that binds selectively to an amyotrophic lateral sclerosis (ALS)-specific epitope.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.